Matteo Giovanni Della Porta

36PUBLICATIONS
384CO-AUTHORS
Regenerative medicine (incl. stem cells)Predictive and prognostic markersMedical mycologyMedical biotechnology diagnostics (incl. biosensors)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|Aug 27, 2026
Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS).

|Jul 30, 2026
ASSESSMENT OF THE IPSS-M IN CHRONIC MYELOMONOCYTIC LEUKEMIA.

|Jul 17, 2026
Comprehensive analysis of prognostic factors in myelodysplastic syndromes with isolated deletion of chromosome 5q.

|Jun 24, 2026
Real-world, multi-omics validation of the clinical relevance of molecular taxonomy for myelodysplastic syndromes (MDS).

|Mar 27, 2026
Molecular-Based Ecosystem to Improve Personalized Medicine in Chronic Myelomonocytic Leukemia.

Luca Lanino, Anthony M Hunter, Nico Gagelmann

|Mar 20, 2026
International testing and refinement of AI algorithms predicting acute leukemia subtypes from routine laboratory data.

Amin T Turki, Yi Fan, Alberto Hernández-Sánchez

Pageof 6

Frequent Collaborators

16 joint publications

Valeria Santini

15 joint publications

Uwe Platzbecker

13 joint publications

Luca Lanino

12 joint publications

Rami S Komrokji